← All organizations

F2G Ltd.

For profitWebsite ↗

Also known as: F2G Biotech GmbH | F2G Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Feb 10, 2022

Timeline

1990s

Jun 1, 1998
F2G Ltd.— Founded

Drugs by trial phase (11 distinct, 20 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (6 own, 0 via acquisition)

Indications

Studied for

Recent trials (20)

NCT05200286Lead sponsorPhase 1Feb 10, 2022
NCT05101187Lead sponsorPhase 3Nov 30, 2021
NCT04752540Lead sponsorPhase 1Jun 17, 2021
NCT04207957Lead sponsorPhase 1Dec 5, 2019
NCT04171739Lead sponsorPhase 1Nov 18, 2019
NCT04039880Lead sponsorPhase 1Jul 30, 2019
NCT03583164Lead sponsorPhase 2Jun 6, 2018
NCT03340597Lead sponsorPhase 1Dec 12, 2017
NCT02912026Lead sponsorPhase 1Jun 1, 2017
NCT03095547Lead sponsorPhase 1May 1, 2017
NCT03076905Lead sponsorPhase 1May 1, 2017
NCT03036046Lead sponsorPhase 1/Phase 2Mar 1, 2017
NCT02856178Lead sponsorPhase 1/Phase 2Sep 1, 2016
NCT02808741Lead sponsorPhase 1Jul 1, 2016
NCT02737371Lead sponsorPhase 1May 1, 2016

Details

Founded: Manchester, GB Jun 1, 1998
Last known activity: Feb 10, 2022